Stockreport

Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update [Yahoo! Finance]

Ikena Oncology, Inc.  (IKNA) 
PDF IK-595 program continues dose escalation in patients with RAS and RAF mutant cancers BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ike [Read more]